Search

Walter E. Webb

Examiner (ID: 5438, Phone: (571)270-3287 , Office: P/1612 )

Most Active Art Unit
1612
Art Unit(s)
1612, 4133
Total Applications
1277
Issued Applications
576
Pending Applications
113
Abandoned Applications
605

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6918746 [patent_doc_number] => 20050096307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions' [patent_app_type] => utility [patent_app_number] => 10/980380 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19935 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096307.pdf [firstpage_image] =>[orig_patent_app_number] => 10980380 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/980380
Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions Nov 2, 2004 Abandoned
Array ( [id] => 6917718 [patent_doc_number] => 20050095279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Transdermal analgesic systems having reduced abuse potential' [patent_app_type] => utility [patent_app_number] => 10/975156 [patent_app_country] => US [patent_app_date] => 2004-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23822 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20050095279.pdf [firstpage_image] =>[orig_patent_app_number] => 10975156 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/975156
Transdermal analgesic systems having reduced abuse potential Oct 26, 2004 Abandoned
Array ( [id] => 7250590 [patent_doc_number] => 20050074497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases' [patent_app_type] => utility [patent_app_number] => 10/971997 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3927 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074497.pdf [firstpage_image] =>[orig_patent_app_number] => 10971997 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/971997
Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases Oct 21, 2004 Abandoned
Array ( [id] => 5080246 [patent_doc_number] => 20070123470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Enhancement of growth hormone levels with a dipeptidyl peptidase IV inhibitor and a growth hormone secretagogue' [patent_app_type] => utility [patent_app_number] => 10/575047 [patent_app_country] => US [patent_app_date] => 2004-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6906 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20070123470.pdf [firstpage_image] =>[orig_patent_app_number] => 10575047 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/575047
Enhancement of growth hormone levels with a dipeptidyl peptidase IV inhibitor and a growth hormone secretagogue Oct 19, 2004 Abandoned
Array ( [id] => 7159781 [patent_doc_number] => 20050084521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Antimicrobial adhesive sheet and antimicrobial method using the same' [patent_app_type] => utility [patent_app_number] => 10/962622 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6021 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084521.pdf [firstpage_image] =>[orig_patent_app_number] => 10962622 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/962622
Antimicrobial adhesive sheet and antimicrobial method using the same Oct 12, 2004 Abandoned
Array ( [id] => 7005897 [patent_doc_number] => 20050171210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Compositions and methods for treatment of cardiovascular disorders and diseases' [patent_app_type] => utility [patent_app_number] => 10/952367 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4891 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171210.pdf [firstpage_image] =>[orig_patent_app_number] => 10952367 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/952367
Compositions and methods for treatment of cardiovascular disorders and diseases Sep 28, 2004 Abandoned
Array ( [id] => 6971363 [patent_doc_number] => 20050037073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof' [patent_app_type] => utility [patent_app_number] => 10/947222 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6452 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037073.pdf [firstpage_image] =>[orig_patent_app_number] => 10947222 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/947222
Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof Sep 22, 2004 Abandoned
Array ( [id] => 6930815 [patent_doc_number] => 20050281850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Cosmetic/dermatological inverse emulsions containing calcitriol and clobetasol 17-propionate' [patent_app_type] => utility [patent_app_number] => 10/944887 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7505 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281850.pdf [firstpage_image] =>[orig_patent_app_number] => 10944887 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/944887
Cosmetic/dermatological inverse emulsions containing calcitriol and clobetasol 17-propionate Sep 20, 2004 Abandoned
Array ( [id] => 6982785 [patent_doc_number] => 20050152855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Materials for enhanced delivery of hydrophilic active agents in personal care formulations' [patent_app_type] => utility [patent_app_number] => 10/945273 [patent_app_country] => US [patent_app_date] => 2004-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13261 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20050152855.pdf [firstpage_image] =>[orig_patent_app_number] => 10945273 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/945273
Materials for enhanced delivery of hydrophilic active agents in personal care formulations Sep 19, 2004 Abandoned
Array ( [id] => 7038817 [patent_doc_number] => 20050158251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Agents for bleaching teeth' [patent_app_type] => utility [patent_app_number] => 10/935813 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5386 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158251.pdf [firstpage_image] =>[orig_patent_app_number] => 10935813 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/935813
Agents for bleaching teeth Sep 7, 2004 Abandoned
Array ( [id] => 5851868 [patent_doc_number] => 20060235059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Cancer treatment with epothilones' [patent_app_type] => utility [patent_app_number] => 10/570850 [patent_app_country] => US [patent_app_date] => 2004-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13192 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20060235059.pdf [firstpage_image] =>[orig_patent_app_number] => 10570850 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/570850
Cancer treatment with epothilones Aug 31, 2004 Abandoned
Array ( [id] => 5603045 [patent_doc_number] => 20060293390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Diflunisal for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 10/569630 [patent_app_country] => US [patent_app_date] => 2004-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5722 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293390.pdf [firstpage_image] =>[orig_patent_app_number] => 10569630 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/569630
Diflunisal for the treatment of cancer Aug 17, 2004 Abandoned
Array ( [id] => 5786847 [patent_doc_number] => 20060205795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Cancer treatment with epothilones' [patent_app_type] => utility [patent_app_number] => 10/561757 [patent_app_country] => US [patent_app_date] => 2004-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14040 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205795.pdf [firstpage_image] =>[orig_patent_app_number] => 10561757 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/561757
Cancer treatment with epothilones Jun 24, 2004 Abandoned
Array ( [id] => 4995078 [patent_doc_number] => 20070010423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Compositions comprising balaglitazone and further antidiabetic compounds' [patent_app_type] => utility [patent_app_number] => 10/561639 [patent_app_country] => US [patent_app_date] => 2004-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5042 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010423.pdf [firstpage_image] =>[orig_patent_app_number] => 10561639 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/561639
Compositions comprising balaglitazone and further antidiabetic compounds Jun 23, 2004 Abandoned
Array ( [id] => 5590892 [patent_doc_number] => 20060040344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Microbial process for the preparation of 7-keto dehydroepiandrosterone and related analogs' [patent_app_type] => utility [patent_app_number] => 10/540370 [patent_app_country] => US [patent_app_date] => 2004-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3958 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040344.pdf [firstpage_image] =>[orig_patent_app_number] => 10540370 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/540370
Microbial process for the preparation of 7-keto dehydroepiandrosterone and related analogs Jun 20, 2004 Abandoned
Array ( [id] => 7276386 [patent_doc_number] => 20040235837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Method for treating fibrotic diseases or other indications IE' [patent_app_type] => new [patent_app_number] => 10/873056 [patent_app_country] => US [patent_app_date] => 2004-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20704 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235837.pdf [firstpage_image] =>[orig_patent_app_number] => 10873056 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/873056
Method for treating fibrotic diseases or other indications IE Jun 20, 2004 Abandoned
Array ( [id] => 7055589 [patent_doc_number] => 20050276762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Topical compositions containing 5\'-adenosine-diphosphate ribose' [patent_app_type] => utility [patent_app_number] => 10/868557 [patent_app_country] => US [patent_app_date] => 2004-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12482 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20050276762.pdf [firstpage_image] =>[orig_patent_app_number] => 10868557 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/868557
Topical compositions containing 5'-adenosine-diphosphate ribose Jun 14, 2004 Abandoned
Array ( [id] => 5608391 [patent_doc_number] => 20060269907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Decontamination of biological fluids using diphenylpyrilium compounds' [patent_app_type] => utility [patent_app_number] => 10/558560 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11798 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269907.pdf [firstpage_image] =>[orig_patent_app_number] => 10558560 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/558560
Decontamination of biological fluids using diphenylpyrilium compounds Jun 3, 2004 Abandoned
Array ( [id] => 5662111 [patent_doc_number] => 20060252707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Pharmaceutical composition for the treatment and/or the prevention of atherosclerosis from infectious origin' [patent_app_type] => utility [patent_app_number] => 10/558503 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12150 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252707.pdf [firstpage_image] =>[orig_patent_app_number] => 10558503 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/558503
Pharmaceutical composition for the treatment and/or the prevention of atherosclerosis from infectious origin May 27, 2004 Abandoned
Array ( [id] => 5924423 [patent_doc_number] => 20060241122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Combination therapy for the treatment of neoplasms' [patent_app_type] => utility [patent_app_number] => 10/559039 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11018 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241122.pdf [firstpage_image] =>[orig_patent_app_number] => 10559039 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/559039
Combination therapy for the treatment of neoplasms May 26, 2004 Abandoned
Menu